However, we can hypothesise that poor Ca2+ signalling may reflect changes in TRPM3 expression that contribute to the pathomechanism of ME/CFS. This evidence concerns the gene TRPM3 and myalgic encephalomeyelitis/chronic fatigue syndrome.